Methylnitronitrosoguanidine

Source: Wikipedia, the free encyclopedia.
Methylnitronitrosoguanidine[1]
Structural formula of methylnitronitrosoguanidine
Space-filling model of the methylnitronitrosoguanidine molecule
Names
Preferred IUPAC name
N-Methyl-N′-nitro-N-nitrosoguanidine
Other names
1-Methyl-3-nitro-1-nitrosoguanidine
N-Methyl-N-nitroso-N′-nitroguanidine
Identifiers
3D model (
JSmol
)
Abbreviations MNNG
ChemSpider
ECHA InfoCard
 100.000.664 Edit this at Wikidata
KEGG
UNII
  • InChI=1S/C2H5N5O3/c1-6(5-8)2(3)4-7(9)10/h1H3,(H2,3,4) ☒N
    Key: VZUNGTLZRAYYDE-UHFFFAOYSA-N ☒N
  • InChI=1/C2H5N5O3/c1-6(5-8)2(3)4-7(9)10/h1H3,(H2,3,4)
    Key: VZUNGTLZRAYYDE-UHFFFAOYAT
  • CN(C(=N[N+](=O)[O-])N)N=O
Properties
C2H5N5O3
Molar mass 147.09 g/mol
Appearance Yellow crystals
Melting point 118 °C (244 °F; 391 K) (decomposes)
reacts violently, slowly hydrolysed
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Methylnitronitrosoguanidine (MNNG

alkyl groups to the O6 of guanine and O4 of thymine, which can lead to transition mutations between GC and AT. These changes do not cause a heavy distortion in the double helix of DNA and thus are hard to detect by the DNA mismatch repair
system.

One of the earliest uses of methylnitronitrosoguanidine was in 1985. A group of scientists tested whether or not the chemical composition of methylnitronitrosoguanidine would directly affect the growth of tumors and cancer cells in rats.[citation needed]

In the experiment, the cancer cells from a Japanese cancer patient was injected into 8 rats. The biochemical tool and showed a decline of cancer cells in a few of the rats' bodies.

In organic chemistry, MNNG is used as a source of diazomethane when reacted with aqueous potassium hydroxide.[4]

MNNG is a probable human carcinogen listed as an

IARC Group 2A carcinogen.[5]

Stability

MNNG produces diazomethane (known DNA methylating agent) in basic aqueous solutions, and nitrous acid (also mutagenic) in acidic solutions.[6]

References

  1. ^ a b Merck Index, 11th Edition, 6017.
  2. PMID 5435496
    .
  3. ^ "Forward and reverse mutagenesis in C. elegans". WormBook. Retrieved 2021-12-01.
  4. ^ T. Howard Black (1983). "The Preparation and Reactions of Diazomethane" (PDF). Aldrichimica Acta. 16 (1). Archived from the original (PDF) on 2019-02-03. Retrieved 2019-02-02.
  5. ^ N-METHYL-N'-NITRO-N-NITROSOGUANIDINE (MNNG), International Agency for Research on Cancer
  6. OCLC 851813793
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Methylnitronitrosoguanidine&oldid=1162960364"